Skip to main content

Closed

ABVC: ABVC BioPharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin1108.9%

ROIC-56.7%

Financially safe

Stretched

Debt / equity0.25×

Interest coverage-36.4×

Current ratio0.12×

ABVC BioPharma, Inc.

ABVCNASDAQ Capital Market·USD·Closed

ABVC BioPharma, Inc.

ABVCNASDAQ·USD·Closed

$1.01

−6.48%

$1.01

−$0.07 (6.48%)

52W Range

5thpctl

Volume

0.18×avg

Mkt Cap

14.64MUSD

P/E

-8.8TTM

Div Yield

–ann

52W Range

5thpctl

Volume

0.18×avg

Market Cap

14.64MUSD

P/E Ratio

-8.8TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings